SCHEMBL30149907

SCHEMBL30149907

Cc1cc(F)cc(-c2ccccc2C#N)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.46
CTSA P10619 2/20 0.46
GABRG2 P18507 4/20 0.44
GABRB3 P28472 4/20 0.44
GABRA5 P31644 3/20 0.44
GABRA3 P34903 3/20 0.44
GABRA1 P14867 3/20 0.44
SSTR2 P30874 3/20 0.41
SSTR5 P35346 1/20 0.41
TSHR P16473 1/20 0.41
NR3C1 P04150 1/20 0.41
GABRA2 P47869 2/20 0.40
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40
PTPN5 P54829 1/20 0.40
AR P10275 1/20 0.40
TRPA1 O75762 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GALR3 O60755 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29662936 0.88 ESR2 (0.53) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL28133054 0.88 ESR2 (0.53) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL13606454 0.81 ESR2 (0.47) ESR2CTSAGABRG2GABRB3GABRA5
SCHEMBL2652196 0.80 ESR2 (0.46) ESR2CTSAGABRG2GABRB3GABRA5
SCHEMBL2648336 0.80 ESR2 (0.46) ESR2CTSAGABRG2GABRB3GABRA5
SCHEMBL5003746 0.77 GABRG2 (0.56) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL3634470 0.77 ACHE (0.43) CTSA
SCHEMBL1372803 0.77 ALOX5AP (0.52) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL28299311 0.75 ESR2 (0.52) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL2183512 0.75 ESR2 (0.47) ESR2GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110337433-B Compounds and pharmaceutical compositions for modulating SGK activity and methods thereof 南京奥利墨斯医药科技有限公司 2023-02-28 CN disclosed